Publications in collaboration with researchers from University of Paris-Sorbonne (8)

2021

  1. Add-on cannabidiol in patients with Dravet syndrome: Results of a long-term open-label extension trial

    Epilepsia, Vol. 62, Núm. 10, pp. 2505-2517

2019

  1. CYR61 triggers osteosarcoma metastatic spreading via an IGF1Rβ-dependent EMT-like process

    BMC Cancer, Vol. 19, Núm. 1

2013

  1. ErbB3 silencing reduces osteosarcoma cell proliferation and tumor growth in vivo

    Gene, Vol. 521, Núm. 1, pp. 55-61

  2. FHL2 Silencing Reduces Wnt Signaling and Osteosarcoma Tumorigenesis In Vitro and In Vivo

    PLoS ONE, Vol. 8, Núm. 1

  3. Zinc chelation: A metallothionein 2A's mechanism of action involved in osteosarcoma cell death and chemotherapy resistance

    Cell Death and Disease, Vol. 4, Núm. 10

2012

  1. Calpain-6 is an endothelin-1 signaling dependent protective factor in chemoresistant osteosarcoma

    International Journal of Cancer, Vol. 130, Núm. 11, pp. 2514-2525

  2. Targeting the E3 ubiquitin casitas B-lineage lymphoma decreases osteosarcoma cell growth and survival and reduces tumorigenesis

    Journal of Bone and Mineral Research, Vol. 27, Núm. 10, pp. 2108-2117

2011

  1. CYR61 downregulation reduces osteosarcoma cell invasion, migration, and metastasis

    Journal of Bone and Mineral Research, Vol. 26, Núm. 7, pp. 1533-1542